Buscar resultados de ensayos clínicos
Perivascular Epithelioid Cell Neoplasms - 25 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: A Phase 2 Study of ABI-009 in Patients With Advanced Malignant PEComa Condición: PEComa Fecha: 2015-07-08 Intervenciones: Drug: ABI-009 |
Withdrawn |
Nombre del estudio: A Phase II Study of Orally Administered BEZ235 Monotherapy in Patients With Metastatic or Unresectable Malignant PEComa Condición: Malignant PEComa (Perivascular Epithelioid Cell Tumors) Fecha: 2012-09-06 Intervenciones: Drug: BEZ235 Patients will be provided with an adequate supply of study treatment for self-administratio |
Completed |
Nombre del estudio: Evaluation of New Biomarkers Predictive of Efficacy Betablockers in PEComa and Vascular Pediatric Tumors Condición:
Fecha: 2014-12-22 Intervenciones: Other: Biopsy |
Not yet recruiting |
Nombre del estudio: Trabectedin Maintenance Post 1st-line in STS Condición: Sarcoma, Soft Tissue Fecha: 2016-10-07 Intervenciones: Drug: Trabectedin Trabectedin 1.2 mg/m² through a central venous catheter as an IV infusion over 24 |
Recruiting |
Nombre del estudio: Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Condición:
|
Recruiting |
Nombre del estudio: Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus Condición: Sporadic Angiomyolipomas (AMLs) Fecha: 2015-08-20 Intervenciones: Drug: Everolimus 10 mg tablets |
Recruiting |
Nombre del estudio: Sirolimus in Treating Patients With Angiomyolipoma of the Kidney Condición: Nonmalignant Neoplasm Fecha: 2005-08-02 Intervenciones: Drug: sirolimus |
Not yet recruiting |
Nombre del estudio: LAM Pilot Study With Imatinib Mesylate Condición: Lymphangioleiomyomatosis Fecha: 2017-04-24 Intervenciones:
|
Recruiting |
Nombre del estudio: A Study of Nintedanib for LymphAngioleioMyomatosis (LAM) Condición: Lymphangioleiomyomatosis Fecha: 2016-10-07 Intervenciones: Drug: Nintedanib Other Name: OFEV |
Recruiting |
Nombre del estudio: Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis Condición: Pulmonary Lymphangioleiomyomatosis Fecha: 2016-03-31 Intervenciones: Drug: saracatinib Subjects will receive enough tablets for 90 days +/- 14 days at each visit. Subject wi |